Ashland reports fourth quarter fiscal 2025 results and issues outlook for full-year 2026
(NYSE:ASH), Sales of $478 million, down eight percent from the prior-year quarter Previously announced carboxymethylcellulose (CMC), methylcellulose (MC), Nutraceuticals and Avoca portfolio optimization initiatives (collectively, Portfolio Optimization) reduced overall sales by approximately $38 million or seven percent versus the prior-year quarter. Excluding these initiatives, sales declined one percent Income from continuing operations of $33 million, […]